Baker Brothers Advisors - BELLEROPHON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$1,832,000
-34.0%
352,928
+0.8%
0.02%
-29.2%
Q2 2015$2,776,000
-13.6%
350,0000.0%0.02%
-11.1%
Q1 2015$3,213,000350,0000.03%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Boxer Capital, LLC 1,857,143$966,0000.37%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 10,574,171$5,499,0000.35%
ARMISTICE CAPITAL, LLC 1,000,000$520,0000.12%
SABBY MANAGEMENT, LLC 789,857$414,0000.02%
Alyeska Investment Group, L.P. 154,290$80,0000.00%
Geneva Advisors, LLC 12,500$7,0000.00%
MORGAN STANLEY 1,000$00.00%
LPL Financial LLC 95,035$51,0000.00%
Citadel Advisors 28,120$15,0000.00%
Renaissance Technologies 239,100$124,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders